Mitchell Kaye

Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA.

Guidehouse, Inc. provides advisory, consulting, outsourcing, technology, and analytics services. It also offers data and analytics, digital enterprise, operations consulting, revenue cycle, risk and compliance, sustainability solutions, and transformation solutions. The company was founded in 1996 and is headquartered in Chicago, IL.

BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts.

Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada.

Founded in 2001 by Mitchell Kaye, Xmark Opportunity Partners LLC is a hedge fund company located in Ridgefield, Connecticut

MedClaims Liaison LLC provides healthcare reimbursement services. The private company is based in Ridgefield, CT. The company was founded in 2009 by Mitchell D. Kaye, Nancy Kaye.